Hidradenitis suppurativa has an enormous impact on patients' lives - 11/12/19
Abbreviations used : HRQOL, HS, MCS, PCS, SF-36
Funding sources: None. |
|
Disclosure: Dr Feldman is a speaker for Janssen and Taro and a consultant and speaker for Galderma, Stiefel/GlaxoSmithKline, Abbott Labs, and Leo Pharma Inc; has received grants from Galderma, Janssen, Abbott Labs, Amgen, Stiefel/GlaxoSmithKline, Celgene, and Anacor; is a consultant for Amgen, Baxter, Caremark, Gerson Lehrman Group, Guidepoint Global, Hanall Pharmaceutical Co Ltd, Kikaku, Lilly, Merck & Co Inc, Merz Pharmaceuticals, Mylan, Novartis Pharmaceuticals, Pfizer Inc, Qurient, Suncare Research, and Xenoport; is on an advisory board for Pfizer Inc; is the founder of and holds stock in Causa Research and holds stock in and is majority owner of Medical Quality Enhancement Corporation; and receives royalties from UpToDate and Xlibris. Dr Pichardo has received consulting support from AbbVie. Dr Cardwell Ms Richardson, Ms Kolli, and Ms Senthilnathan have no conflicts of interest to declare. |
|
This work was presented at the Southeastern Consortium for Dermatology meeting, Charleston, SC, November 2018. |
Vol 82 - N° 1
P. 236-238 - janvier 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?